These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34310561)

  • 1. [Progress in cardiovascular prevention: from risk charts to polygenic risk score and precision prevention].
    Boccanelli A; Bottà G; Vanuzzo D
    G Ital Cardiol (Rome); 2021 Aug; 22(8):599-605. PubMed ID: 34310561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease.
    Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H
    Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of polygenic risk scores and digital technologies for INNOvative personalized cardiovascular disease PREVention in high-risk adults: protocol of a randomized controlled trial.
    Pastorino R; Pezzullo AM; Agodi A; de Waure C; Mazzucco W; Russo L; Bianchi M; Maio A; Farina S; Porcelli M; Tona DM; Di Pumpo M; Amore R; Wachocka M; Pasciuto T; Barchitta M; Magnano San Lio R; Favara G; Tuttolomondo A; Tramuto F; Morello G; De Bella DD; Fruscione S; Severino A; Liuzzo G; Boccia S
    Front Public Health; 2024; 12():1335894. PubMed ID: 38947346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of high risk individuals to optimise strategies for primary prevention of cardiovascular diseases.
    Giampaoli S; Palmieri L; Mattiello A; Panico S
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):79-85. PubMed ID: 15871855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis.
    Uthoff H; Staub D; Socrates T; Meyerhans A; Bundi B; Schmid HP; Frauchiger B
    Vasa; 2010 Nov; 39(4):325-33. PubMed ID: 21104622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Italian cardiovascular mortality charts of the CUORE Project: are they comparable with the SCORE charts?].
    Donfrancesco C; Palmieri L; Vanuzzo D; Panico S; Cesana G; Ferrario M; Pilotto L; Giampaoli S;
    G Ital Cardiol (Rome); 2010 Feb; 11(2):148-53. PubMed ID: 20408479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.
    Mendis S
    Prog Cardiovasc Dis; 2010; 53(1):10-4. PubMed ID: 20620420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Do We Incorporate Polygenic Risk Scores in Cardiovascular Disease Risk Assessment and Management?
    Hadley TD; Agha AM; Ballantyne CM
    Curr Atheroscler Rep; 2021 Apr; 23(6):28. PubMed ID: 33791884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cardiovascular mortality charts of the CUORE project: are they comparable with the SCORE charts?
    Donfrancesco C; Palmieri L; Cooney MT; Vanuzzo D; Panico S; Cesana G; Ferrario M; Pilotto L; Graham IM; Giampaoli S
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):403-9. PubMed ID: 20351552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
    Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
    Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of cardiovascular disease in Greece: Greek results of the EURIKA study.
    Elisaf M; Tzouvelekis E; Nikas N;
    Hellenic J Cardiol; 2014; 55(3):217-26. PubMed ID: 24862614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of High-Sensitivity Cardiac Troponin T Compared with Risk Scores in Stable Cardiovascular Disease.
    Biener M; Giannitsis E; Kuhner M; Zelniker T; Mueller-Hennessen M; Vafaie M; Trenk D; Neumann FJ; Hochholzer W; Katus HA
    Am J Med; 2017 May; 130(5):572-582. PubMed ID: 28011313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polygenic Risk Score for Cardiovascular Diseases in Artificial Intelligence Paradigm: A Review.
    Khanna NN; Singh M; Maindarkar M; Kumar A; Johri AM; Mentella L; Laird JR; Paraskevas KI; Ruzsa Z; Singh N; Kalra MK; Fernandes JFE; Chaturvedi S; Nicolaides A; Rathore V; Singh I; Teji JS; Al-Maini M; Isenovic ER; Viswanathan V; Khanna P; Fouda MM; Saba L; Suri JS
    J Korean Med Sci; 2023 Nov; 38(46):e395. PubMed ID: 38013648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
    Walli-Attaei M; Joseph P; Rosengren A; Chow CK; Rangarajan S; Lear SA; AlHabib KF; Davletov K; Dans A; Lanas F; Yeates K; Poirier P; Teo KK; Bahonar A; Camilo F; Chifamba J; Diaz R; Didkowska JA; Irazola V; Ismail R; Kaur M; Khatib R; Liu X; Mańczuk M; Miranda JJ; Oguz A; Perez-Mayorga M; Szuba A; Tsolekile LP; Prasad Varma R; Yusufali A; Yusuf R; Wei L; Anand SS; Yusuf S
    Lancet; 2020 Jul; 396(10244):97-109. PubMed ID: 32445693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up: comparison between the algorithms of the Framingham Heart Study, the European SCORE and the Italian 'Progetto Cuore'.
    Novo S; Carità P; Lo Voi A; Muratori I; Tantillo R; Corrado E; Kalodiki E; Novo G
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):91-96. PubMed ID: 30557211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy.
    Presta V; Figliuzzi I; Miceli F; Coluccia R; Fogacci F; Cicero AFG; Ferrucci A; Borghi C; Volpe M; Tocci G;
    Atherosclerosis; 2019 Jun; 285():40-48. PubMed ID: 31003091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular Risk Assessment: preliminary results].
    Palmieri L; Rielli R; Demattè L; Donfrancesco C; La Terza G; De Sanctis Caiola P; Dima F; Lo Noce C; Giannelli AM; Brignoli O; Cuffari A; De Rosa M; Addis A; Laurendi G; Giampaoli S
    G Ital Cardiol (Rome); 2010 Feb; 11(2):154-61. PubMed ID: 20408480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?
    Singh SS; Pilkerton CS; Shrader CD; Frisbee SJ
    BMC Public Health; 2018 Apr; 18(1):429. PubMed ID: 29609588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.